Performance characteristics for some typical QT study designs under the ICH E-14 guidance.

Area of Science:

• Pharmacology
• Clinical Trials
• Biostatistics

Background:

• International Conference on Harmonization (ICH) E14 guidance mandates thorough QT (TQT) studies for drug development.
• The ICH E14 Statistics Group recommended the intersection-union test (IUT) to exclude clinically significant QT prolongation.

Purpose of the Study:

• To assess the false positive rate of the IUT in TQT studies.
• To evaluate the impact of study design and patient factors on IUT performance.

Main Methods:

• Simple simulation experiments were conducted.
• Analyzed 4 recently completed TQT trials.
• Varied study design, sample size, and patient status.

Main Results:

• Positive TQT study rates ranged from negligible to nearly 60% without any drug effect.
• Inclusion of minor QT prolongations (up to 5 ms) raised positive rates to 80% in specific designs.
• Demonstrated high false positive rates dependent on study parameters.

Conclusions:

• The IUT exhibits significant limitations in reliably excluding QT prolongation effects.
• Certain TQT trial designs may lead to misinterpretation of results due to IUT conservatism.
• Re-evaluation of IUT application in TQT studies is warranted for accurate drug safety assessment.